Top 35 Medical Device Angel Investors in Israel (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Shimon Eckhouse
Angel
|
2 | Israel | Series B, Series C | Health Care, Medical Device, Medical | |
|
Yehuda Zisapel
Angel
|
2 | Israel | Series A, Seed | Medical Device, Medical, Health Care | |
|
Danny Hadar
Angel
|
2 | Israel, United States | Seed, Series B | Software, Artificial Intelligence, Internet | $65k–$11M |
|
Zohar Gilon
Angel
|
2 | Israel, United States | Seed, Series A, Series B | Software, Internet, Health Care | $1.5M–$15M |
|
Prof. Rafael Beyar
Angel
|
2 | Israel | Series A, Seed | Medical Device, Medical, Machine Learning | $1M–$17M |
|
Mazal CB
Angel
|
2 | Israel | Seed, Pre-Seed | Health Care, Therapeutics, Medical Device | |
|
Ron C
Angel
|
2 | Israel | Seed, Pre-Seed | Health Care, Therapeutics, Medical Device | |
|
Jordan Feiger
Angel
|
2 | Israel | Seed, Series A | Medical, Health Care, Medical Device | |
|
Marius Nacht
Angel
|
1 | Israel, United States, Germany | Series A, Seed, Series B | Artificial Intelligence, Health Care, Machine Learning | $3M–$120M |
|
Jacques R. Seguin
Angel
|
1 | Israel, Switzerland | Seed, Pre-Seed | Medical, Medical Device, Health Care | |
|
Ran Tuttnauer
Angel
|
1 | Israel, Canada, United States | Seed, Series A | Health Care, Big Data, Internet | |
|
Itsik Danziger
Angel
|
1 | Israel | Series A | Medical, Hospital, Health Care | |
|
Ole T. Jensen
Angel
|
1 | Israel | Biotechnology, Medical Device | ||
|
Haim Chizic
Angel
|
1 | Israel | Seed | Medical Device, Clinical Trials, Health Diagnostics | |
|
Lewis Pell
Angel
|
1 | Israel, United States | Post-IPO Equity | Health Care, Medical, Therapeutics | |
|
Amir Gross
Angel
|
1 | Israel | Medical, Health Care, Medical Device | ||
|
Shane Neman
Angel
|
1 | United States, Kenya, Spain | Seed, Series A | Health Care, Software, Artificial Intelligence | $125k–$700M |
|
Alan Patricof
Angel
|
1 | United States, Kenya, Spain | Series A, Seed | Finance, Financial Services, FinTech | $1.5M–$15M |
|
Dov Moran
Angel
|
1 | Israel, United States | Series A, Seed, Series B | Semiconductor, Hardware, Health Care | |
|
Daniel Koss
Angel
|
1 | Israel | Seed | Medical Device, Clinical Trials, Health Diagnostics | |
|
Jim Elkind
Angel
|
1 | Israel | Series A | Medical, Hospital, Health Care | |
|
Michal Efrat Zarfati
Angel
|
1 | Israel | Seed, Pre-Seed | Wearables, Medical Device, Rehabilitation | |
|
Shahar Tzafrir
Angel
|
1 | Israel, United States | Series A, Seed, Series B | Software, Artificial Intelligence, Biotechnology | $3M–$40M |
|
Tzachi Arabov
Angel
|
1 | Israel | Seed | Medical Device, Clinical Trials, Health Diagnostics | |
|
Oren Dobronsky
Angel
|
1 | United States, Israel | Seed, Series A, Angel | FinTech, Payments, Software | $1M–$17M |
|
Moshe Yanai
Angel
|
1 | Israel, United States | Seed, Series B, Series D | Data Storage, Artificial Intelligence, Medical | |
|
Jeremy Coller
Angel
|
1 | Israel, United Kingdom | Seed, Pre-Seed, Series A | News, Video, Mobile | $100k–$9.2M |
|
Benny Levin
Angel
|
1 | Israel | Series A | Medical, Hospital, Health Care | |
|
Rafi Benary
Angel
|
1 | Israel | Pre-Seed | Medical, Medical Device, Health Diagnostics | |
|
Rafi Gidron
Angel
|
1 | Israel, United States, United Kingdom | Seed, Pre-Seed, Angel | Artificial Intelligence, Cyber Security, Financial Services | $2M–$8M |
|
Avishai Abrahami
Angel
|
1 | Israel, United States, Italy | Seed, Pre-Seed, Series A | Software, Information Technology, Artificial Intelligence | $250k–$35M |
|
Andrej Steinberg
Angel
|
1 | United States, Germany, Israel | Seed, Pre-Seed, Series A | Health Care, Medical, Financial Services | $3.4M–$6M |
|
Ron Zuckerman
Angel
|
1 | Israel, United States, China | Series A, Seed | Internet, Video, Apps | $500k–$8M |
|
Avi Kornreich
Angel
|
1 | Israel | Series A | Medical, Hospital, Health Care | |
|
Shmuel Cabilly
Angel
|
1 | Israel, United States | Series B, Series C | Health Care, Medical, Artificial Intelligence | |
| Access all 53 angel investors in Israel Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Shimon Eckhouse, Ph.D., is a leading Israeli medical entrepreneur who has founded more than 20 startups including Syneron Medical Ltd., Lumenis Ltd., Ventor and Real-View Imaging. He is the current Chairman of Butterfly Medical Ltd, Active Chairman of Synerion Medical and serves as Executive of Matteris Ltd. Shimon Eckhouse served as the ChiefExecutive Officer of Syneron Medical Ltd. from April 17, 2013 to February 18, 2014. Shimon Eckhouse Co-Founded Colorchip Inc. in 2000 and served as its Chairman from 2003 to January 2004 and as Chief Executive Officer from 2001 to 2003. He served as the Chairman and Chief Executive Officer of ESC Medical Systems since its inception in 1992. He was also a co-founder and Chairman of Ventor Medical Technologies Ltd. He Co-Founded at Navotek Medical Ltd. Mr. Eckhouse took ESC public in 1996 and raised more than $250M in public offerings. He served as Chairman of Syneron Medical Ltd. from May 2004 to May 2013. He worked at Lumenis Ltd. Prior to that, Shimon Eckhouse served as Head of Product Development and Technical Director at Maxwell Technologies in San Diego, California. From 1969 to 1986, he worked at Rafael, Armament Development Authority of Israel as a Scientist, Team Leader and Head of Department and was active in various areas of research and development including lasers and electro-optics. Shimon Eckhouse has been the Founder of Orsense, Ventor, Tulip, Cardiodex, Opticul Diagnostic, C3D and NanoCyte, Inc. Shimon Eckhouse serves as the Chairman of Fluorinex Active Ltd. Shimon Eckhouse serves as the Chairman at Starling Advanced Communications Ltd. since July 2010. He serves as Chairman at OrSense Ltd. He also serves as the Chairman of the Board of Ossense Ltd., Navotek Medical Ltd., and Replicom Ltd. and Edge Medical Devices Ltd. He has been a Director at Syneron Medical Ltd. since May 2004. He serves as a Director of Cardiodex and NanoCyte, Inc. Shimon Eckhouse serves as a Member of Advisory Board of Agate Medical Investments LP and JGV Growth Equity Fund, L.P. Shimon Eckhouse serves as a Director of the Technion Israeli Institute of Technology. He served as a Director of Zend Technologies Ltd. He served as a Director of WideMed Ltd. Shimon Eckhouse has more than 25 registered patents and published more than 50 papers in leading reference journals and conferences. He holds a Ph.D. in Physics from the University of California at Irvine and a B.Sc. in Physics from the Technion Israeli Institute of Technology.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series B, Series C
- Geography: Israel
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Anchora Medical — Anchora Medical focuses in simplifying of suturing in endoscopic and open surgery applications. The company develops a unique, single-use automatic suturing device for minimal invasive surgery.
- Serenno Medical — Serenno Medical is a medical device company creating a urine-output measuring device for the ICU. The company is the developer of a bedside urine output measuring device for hospitalized patients, offering accurate and automatic measurements with low costs, less workload, and improved patient safety.Serenno Medical was founded in 2017 and isheadquartered in Yokne'am Illit, Israel.
- RealView Imaging — RealView Imaging is pioneering the field of interactive live holography, creating a new dimension for Augmented Reality applications.
Mr. Yehuda Zisapel (EE,MSc, MBA, DHC) is the founder and president of the RAD-Bynet Group, a leading pioneering association of Israeli companies active in the development, production and marketing of innovative solutions for the data communications industry, and Chairman of RAD. The RAD-Bynet Group grew out of Bynet Data Communications, whichMr. Zisapel founded in 1975 as a small private company that marketed data communications products. Bynet represented major international vendors and was the first to introduce cutting-edge technologies into the Israeli market. Today, the Bynet Group is comprised of eight companies active in both the Israeli and Eastern European markets in such fields as systems integration, cabling, testing, outsourcing, and software development. Following the arrival of Mr. Zisapel’s brother, Zohar, who joined him in 1981, a wide range of industrial activity was spawned from within the newly established RAD, the first of the RAD Group companies. In the years following its successful launch, twenty-four additional independent hi-tech companies were opened to develop, produce and market a wide variety of advanced data communications products.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series A, Seed
- Geography: Israel
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Carteav — Autonomous Low Speed Vehicle
- Rewire — Secure financial services designed to help migrants make cross-border money transfers. Rewire offers great rates, fast delivery, multilingual customer support
- Laminate Medical — Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the firstyear. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications.
For the last 10 years, I have been active within the Israeli and US startup ecosystems where I completed 20+ seed investments in companies such as Geoforce (acquired by LLR), Bonobo (acquired by Salesforce), Optitex (acquired by Efi), Keeprz (acquired by Como), Drippler (acquired by Soluto), Snyk (Unicorn) and few others. I am passionate for seedinvestments, creative ideas, risk taking and supporting entrepreneurs.Prior to that, I founded 2 companies, Blue Sky (Energy) and Sinusafe (Medical) after working as a software engineer for 7 years.I grew up in Israel, and lived in the US for 5 years while completing my MBA from Duke. I love all kinds of extreme sports, and particularly kite surfing and snowboarding.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Internet
- Stage:Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 23
- Round size: Seed $65k–$11M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Laxis — Learn how UX designers, product managers, market research, consultants, and attorneys use conversation Intelligence to supercharge their business and increase revenue. Learn more.
- Deci AI — Deci enables deep learning to live up to its true potential by using AI to build better AI. With the company’s end-to-end deep learning acceleration platform, AI developers can build, optimize, and deploy faster and more accurate models for any environment, including cloud, edge or mobile. With Deci’s platform, developers can increase deeplearning model inference performance by 3x-15x, on any hardware, while still preserving accuracy. This translates directly into new use cases on limited hardware, substantially shorter development cycles, and reduced compute costs by up to 80%. The platform is powered by Deci’s Automated Neural Architecture Construction (AutoNAC) technology, an algorithmic optimization engine that squeezes maximum utilization out of any hardware. The AutoNAC engine contains a Neural Architecture Search (NAS) component that redesigns a given trained model’s architecture to optimally improve its inference performance (throughput, latency, memory, etc.) for specific target hardware while preserving its baseline accuracy. Deci achieved a record-breaking 11.8x accelerated inference speedup on Intel CPUs at MLPerf Industry Benchmark and has been named to the CBInsights top 100 AI companies. Led by a team of world-class deep learning experts, Deci lets AI developers focus on what they do best - creating innovative AI-based solutions for our world’s most complex problems.
- Velocity — Accelerate the way you build and deliver products. Spin up fully isolated, production-like environments in seconds. Work with your existing dev toolbox.
Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.
Show more...Investment focus
- Industry: Software, Internet, Health Care
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 34
- Round size: Seed $1.5M–$9.3M; Series A $1.6M–$11M; Series B $4.5M–$15M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- CADY — CADY's mission is to fully automate the inspection and verification of Printed Circuit Board (PCB) schematics, using AI technology.
- Hoopo — Hoopo assists companies to boost their logistics operations with cost and power-efficient, LPWA tracking solutions
- Body Vision Medical — Bronchoscopy, reimagined. Using Artificial Intelligence, the Body Vision Platform delivers real-time imaging without the use of electromagnetic sensors.
Prof. Rafael Beyar
Show more...Investment focus
- Industry: Medical Device, Medical, Machine Learning
- Stage:Series A, Seed
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Series A $1M–$17M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
Mazal CB
Show more...Investment focus
- Industry: Health Care, Therapeutics, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Ron C
Show more...Investment focus
- Industry: Health Care, Therapeutics, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Jordan Feiger
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VeinWay — VeinWay is a medical device firm that develops a catheter for recanalizing chronic venous occlusions due to blockage or disease.
Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Machine Learning
- Stage:Series A, Seed, Series B
- Geography: Israel, United States, Germany
Investor stats
- Total investments: 33
- Round size: Seed $3M–$120M; Series A $5M–$23M; Series B $8M–$83M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- CPTx — At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
- BioGenCell — Ushering in a New EraIn Cellular Medicine Making personalized cell-therapy a reality for every patient with a degenerative microvascular disease.
- 1E Therapeutics — 1E Therapeutics is a breakthrough, drug development company creating RNA-targeting therapeutics based on a proprietary drug design platform.
Jacques Seguin is the Chairman Of The Board at Emanate Biomedical. He Attended Paris-Sud University (Paris XI) during 1975-1985.
Show more...Investment focus
- Industry: Medical, Medical Device, Health Care
- Stage:Seed, Pre-Seed
- Geography: Israel, Switzerland
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pi-Cardia — Pi-Cardia. Next Generation Valve Repair. The next frontier of treatment options for structural heart disease that provides a safe, effective, and affordable non-implant-based catheter solutions.
- Althea Medical — Althea Medical is a creator of catheter devices for the treatment of patients with sub- or major pulmonary emboli. The company is developing a catheter-based solution for treating patients suffering from massive and sub-massive Pulmonary Embolism (PE). Althea Medical was established in 2020 in Tel Aviv, Israel.
- CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ran Tuttnauer
Show more...Investment focus
- Industry: Health Care, Big Data, Internet
- Stage:Seed, Series A
- Geography: Israel, Canada, United States
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Innovopro — InnovoPro is committed to bringing unique plant-based protein ingredients to the global food market in order to create nutritious, tasty, safe, and sustainable food products. With an excellent nutritional profile, free from properties and wide usability in the food industry, InnovoPro’s chickpea protein is the best choice for the growingplant-based protein market.InnovoPro was founded on 2013 by Dr. Ascher Shmulewitz an experienced inventor and investor, and has made considerable progress in developing chickpea proteins and other chickpea ingredients.InnovoPro has been recognized as an innovator of disruptive technology in the food industry.
- Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
- Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders.
Itsik Danziger - Chairman of the Board @ The Center for Educational Technology (CET)
Show more...Investment focus
- Industry: Medical, Hospital, Health Care
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
Ole T. Jensen
Show more...Investment focus
- Industry: Biotechnology, Medical Device
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nobio — NobioTM developed game-changing technology with the goal to prevent medical device contamination indefinitely, as the first and only fully-integrated anti-biofilm solution. The technology core consists of extremely potent particles which are covered with a high concentration of highly-active anti-microbial structures that kill bacteria uponcontact. The NobioTM particles can be permanently embedded in many products and materials to inhibit formation of biofilm, indefinitely.
Haim Chizic is an individual investor.
Show more...Investment focus
- Industry: Medical Device, Clinical Trials, Health Diagnostics
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Lewis Pell was appointed to our Board of Directors and was unanimously elected to serve as Non-Executive Chairman of the Board on December 12, 2011. Pell was a member of Radiancy’s Board since 1998. Pell has founded over a dozen successful medical technology companies during the past three decades. In 1979, he founded Pentax PrecisionInstruments, which was sold to Asahi Optical Co. in 1990. In 1983, he founded American Endoscopy Inc., which was sold to C.R. Bard, Inc. (BCR-NYSE) in 1986. In 1984, he founded Versaflex Inc., which was sold to Medtronic in 1988. In 1989, he founded Heart Technology Corp., which went public in the U.S. in 1992 and was sold to Boston Scientific Corp. (BSX-NYSE) in 1995. In 1991, he founded InStent Inc., which became a public company in 1995 and was sold to Medtronic in 1996. In 1994, he founded Influence Inc., which was sold to American Medical Systems Inc. in 1999. Working with Shlomo Ben-Haim, Pell founded Biosense Inc. in 1994, which was sold to Johnson & Johnson in 1997. He is currently chairman and an investor for a number of private medical device companies. In 1992, he founded and remains the chairman of Vision-Sciences, Inc. (VSCI-NASDAQ). Pell has a B.S. in political science from Brooklyn College and over 20 years of experience in the medical technology industry. Pell was selected to serve on the Company’s board because of his over thirty-years’ experience in leadership roles in the medical device industry.
Show more...Investment focus
- Industry: Health Care, Medical, Therapeutics
- Stage:Post-IPO Equity
- Geography: Israel, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
- Vision Sciences — Vision-Sciences, Inc., is a medical device company. The Company designs, develops, manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, EndoSheath technology. The Company produces and markets Endoscopes, such as cystoscopes, ureteroscopes, laryngoscopes,otoscopes, sinuscopes, trans-nasal esophagoscopy (TNE) and bronchoscopes for medical use and borescopes for industrial use, and digital processing units (DPU). The Company offers Urgent PC Neuromodulation System, a nerve stimulation device that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). It also offers Macroplastique, an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence. It markets additional bulking agents: PTQ for the treatment of fecal incontinence and the VOX for vocal cord augmentation.
Amir Gross is the CEO of Cardiovalve.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- BrainQ — BrainQ is developing breakthrough precision neurology therapies using Brain Computer Interface technology....
Founder of EZ Texting and JoonBug. Serial entrepreneur and investor in Tech, Real Estate & Hospitality.cA forward-thinking problem solver, consummate optimist and serial entrepreneur, Shane Neman is the prototypical businessman of our modern era. His experience and expertise in business span numerous industries, from technology andtelecommunications to real estate and hospitality. After leaving NYU Medical School early, he started three industry-shifting tech startups (two of them – EZ Texting and JoonBug – acquired) with hundreds of employees and tens of thousands of customers. As an insightful startup backer, Shane’s portfolio includes companies such as Convoy, Prose, Impossible Foods, Universal Standard, Apostrophe, MeetMindful, MapAnything, VinePair and Smylen. Shane is also a prolific real estate developer and investor. From commercial shopping and industrial centers to residential buildings, he owns more than two dozen large-scale properties across the U.S. He holds a degree in Computer Science from New York University, where he received the prestigious Barry M. Goldwater scholarship and was a member of the Phi Beta Kappa academic honor society.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Series A
- Geography: United States, Kenya, Spain
Investor stats
- Total investments: 107
- Round size: Seed $125k–$6M; Series A $2.5M–$700M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hark —
- NOVOS — Science-backed longevity supplements and tools, now supported by placebo-controlled human clinical research. Designed to slow biological aging and extend healthspan.
- CG Oncology — CG Oncology is a late-stage pharmaceutical company that is passionate about developing and delivering bladder-sparing immunotherapies.
Alan Patricof is the founder and Chairman Emeritus and was a managing director of Greycroft. He is a Co-founder and Chairperson at Primetime Partners and was a Founder at Apax Partners. Alan attended Columbia Business School and The Ohio State University.
Show more...Investment focus
- Industry: Finance, Financial Services, FinTech
- Stage:Series A, Seed
- Geography: United States, Kenya, Spain
Investor stats
- Total investments: 34
- Round size: Seed $1.5M–$8M; Series A $4M–$15M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Verse — Verse is the payments technology platform that takes the friction out of storing, spending and sharing money. The mobile app allows you to share payments easily, instantly and with no hidden fees and also allows you to choose whether your transactions are private or public so that you can have fun while keeping track of your financial activities.Verse is available for both Android and iOS-based phones and transactions are completed in less than two business days. The company was founded in 2016 and is based in Barcelona, Spain.
- Leena AI — Leena AI is an autonomous conversational AI-backed platform that helps enterprises better employee experience. The platform is powerful, flexible, and made to meets the needs of any enterprise. With Leena AI, companies can eliminate the need for HR staff to work on tasks such as answering policy-related questions, knowledge management,generating employee documents on demand, and managing employee tickets so they can focus on high-value activities.Leena AI plays well with 20 plus platforms, including SAP SuccessFactors, ADP, Oracle, Workday, and Microsoft Office 365. It is trusted by 1M employees across companies like Nestle, Puma, AirAsia, Coca-cola, Lafarge Holcim, and Abbott.The platform is capable of handling every aspect of employee experience across the employee lifecycle. From FAQ automation and employee engagement right up to employee onboarding, the platform aims to help organizations streamline all HR workflows.
- Racket — Let's make a racket.
Dov Moran is the Managing Partner of Grove Ventures. He previously worked at modu as the Founder, Chairman, and CEO. Dov Moran attended Technion.
Show more...Investment focus
- Industry: Semiconductor, Hardware, Health Care
- Stage:Series A, Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 24
- Lead/follow: no public data
Portfolio highlights
- Rapid — RapidAPI is an API Hub that enables over 3 million developers to find, manage, and connect to APIs. RapidAPI lets developers manage all API integrations from one place and gives real-time performance metrics. RapidAPI was founded in 2014 and is headquartered in San Francisco, California.
- Triple Jump Medical — Triple Jump Medical is a developer of an insulin pump intended to treat diabetic patients.
- Sensible Medical Innovations — Sensible Medical Innovation Ltd. is introducing a breakthrough sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today’s biggest burden on US and worldwide healthcare budgets.
Daniel Koss is an individual investor.
Show more...Investment focus
- Industry: Medical Device, Clinical Trials, Health Diagnostics
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jim Elkind is a private healthcare investor.
Show more...Investment focus
- Industry: Medical, Hospital, Health Care
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
Michal Efrat Zarfati
Show more...Investment focus
- Industry: Wearables, Medical Device, Rehabilitation
- Stage:Seed, Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- 6Degrees — 6Degrees has developed an adaptive hands free controller that gives people independence and choice by making devices accessible. Their patented wireless controller can be utilized to operate any smart device - including smart phones, tablets and PCs. Crescent has deep applicability in the fields of AR/VR, defense, and assistive technologies
- Pink Of View —
Shahar is a Managing Partner at TLV Partners, investing in the idea/seed stage. Over the past decade, he has focused on the intersection of AI as it addresses commercial problems across sectors, including Developer Tools, Biotech, Cloud Native, Construction, Customer Retention, Data Centers, Drug Discovery, Enterprise Software, Health Care,and Taxes.His investment portfolio at TLV Partners includes Buildots, Bond (acquired by Reef), Canopy Immuno-Therapeutics, Covver, Churney, Deepcure, EverAfterAI, Gelt, Granulate (acquired by Intel), Guesty (exit via secondary), Immunai, Odo (acquired by Checkpoint), ScyllaDB, Solvo, Silverfort, and Unleash. He also serves as a Board Observer at Aidoc on behalf of the founders.Before joining TLV Partners, Shahar was a General Partner at Magma Venture Partners, working with funds III and IV. His investment portfolio included Aidoc, Applitools (acquired by Thoma Bravo), Cloudendure (acquired by Amazon), Coretigo, Guesty (exit via secondary), Indegy (acquired by Tenable), ScyllaDB, Syte, Teridion, and Tonkean.Before his venture capital career, Shahar spent 15 years across three startups: Federation (acquired by Cordys), Oblicore (acquired by CA), and DigitalFuel (acquired by VMWare).He served as a software programmer in Israel’s Defense Forces for six years, earning three annual distinction awards at the Unit, Division, and Corps levels.He holds an LL.B., graduating Summa Cum Laude as the Valedictorian. Outside work, he is an amateur nature photographer and a chess player interested in Advanced Chess, a blend of AI and human strategy.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 21
- Round size: Seed $3M–$5.5M; Series A $3M–$40M; Series B $20M–$30M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Aidoc — Aidoc is an Israel-based startup providing artificial intelligence tools for radiologists. Their products help detect and pinpoint critical anomalies for radiologists through deep learning and AI algorithms that analyze medical images and patient data. Aidoc eases up the work list and frees up time and attention to what matters. The startupdeidentifies these and sends them onto Aidoc’s cloud, where algorithms identify and highlight abnormalities before returning the images to radiology workstations for reidentification.Aidoc's s solutions aid radiologists in reducing turnaround time and increasing quality and efficiency by flagging acute anomalies in real-time. It also offers tests for intracranial hemorrhages and spinal fractures, plus several chest exams for pulmonary embolisms, pneumothorax, rib fractures, and lung nodules.Aidoc was founded by Guy Reiner, Elad Walach, and Michael Braginsky in 2016 and is headquartered in Tel Aviv, Israel.
- Converge Bio — Converge Bio is accelerating drug development through GenAI-powered innovations in discovery, molecule design and manufacturing to create the therapies of tomorrow, today.
- Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Tzachi Arabov is a owner of ACRO.
Show more...Investment focus
- Industry: Medical Device, Clinical Trials, Health Diagnostics
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Entrepreneur at heart. Angel investor in past two decades. I had the privilege to invest in the following startups, mostly at seed level: Houzz(Unicorn), TripActions(Unicorn), Hippo(Unicorn), HomeLight, Domestika, Loop Commerce, RedKix, Duda, YouNow, OwnerListens... But mostly, I am known as Oren from Oren's Hummus :)
Show more...Investment focus
- Industry: FinTech, Payments, Software
- Stage:Seed, Series A, Angel
- Geography: United States, Israel
Investor stats
- Total investments: 13
- Round size: Seed $1M–$17M; Series A $2M–$11M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Linguana — Linguana builds and monetizes your fully localized YouTube channels in new languages to reach new audiences across the globe and monetize them.
- Openbase — Find and compare the best open-source packages in hundreds of categories - withpowerful metrics and user reviews
- Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
Moshe Yanai has been instrumental in the development of some of the most advanced and successful storage technologies in the history of the industry. Mr. Yanai began his career in the 1970s, building IBM-compatible mainframe storage based on minicomputer disks. He went on to develop high-end storage systems for Nixdorf, and in the late 1980s,joined EMC, leading the team that developed Symmetrix (today’s “DMX series”). As Vice President of EMC’s Symmetrix group, Mr. Yanai was responsible for design and development of all hardware and software products for EMC’s industry-leading enterprise storage systems. Based in Hopkinton, Massachusetts, EMC’s Symmetrix group grew from only one employee in 1987 to more than 3500 under his leadership. Mr. Yanai graduated in 1975 from the Technion, Israel Institute of Technology with a Bsc in Electrical Engineering. He holds over 40 patents for various innovative storage hardware and software-related technologies.
Show more...Investment focus
- Industry: Data Storage, Artificial Intelligence, Medical
- Stage:Seed, Series B, Series D
- Geography: Israel, United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Infinidat — Infinidat's enterprise storage solutions offer the performance, flexibility and reliability necessary to support today's data intensive enterprises.
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
Jeremy Joseph Coller is based out of Greater London, England and is the Chief Investment Officer of Coller Capital. Jeremy attended the Unversity of Sussex.
Show more...Investment focus
- Industry: News, Video, Mobile
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United Kingdom
Investor stats
- Total investments: 7
- Round size: Seed $3.5M–$4.5M; Pre-Seed $100k–$370k; Series A $2.3M–$9.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Castor Technologies LTD — CASTOR is a complete decision support system for utilizing industrial additive manufacturing
- Penfold — Our flexible, simple and powerful pension is designed to get you to your saving goals and stay with you for life, whichever direction it takes you.
- X-trodes — X-trodes is a neurotechnology company developing wearable biosensors for EEG, EMG and physiological monitoring, enabling real-world human-machine interaction and remote health insights.
Benny Levin is a founder and former CEO of NICE.
Show more...Investment focus
- Industry: Medical, Hospital, Health Care
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
Rafi Benary is the Co-founder at Innoventric and he holds a Masters’ degree from the New York University in Material Science and a Mechanical Engineering. He is an entrepreneur of 4 start-up companies, bringing them from inception to clinical stage through effective planning and execution.
Show more...Investment focus
- Industry: Medical, Medical Device, Health Diagnostics
- Stage:Pre-Seed
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Althea Medical — Althea Medical is a creator of catheter devices for the treatment of patients with sub- or major pulmonary emboli. The company is developing a catheter-based solution for treating patients suffering from massive and sub-massive Pulmonary Embolism (PE). Althea Medical was established in 2020 in Tel Aviv, Israel.
Rafi Gidron is the Founder and Chairman of Israel Brain Technologies. He previously worked at Lucent as a VP of Optical networks. Rafi Gidron attended Columbia University.
Show more...Investment focus
- Industry: Artificial Intelligence, Cyber Security, Financial Services
- Stage:Seed, Pre-Seed, Angel
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 23
- Round size: Seed $2M–$8M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- CADY — CADY's mission is to fully automate the inspection and verification of Printed Circuit Board (PCB) schematics, using AI technology.
- Vyzer — One platform for investment tracking, financial planning, data-driven insights, document analysis & more! Ideal for diverse portfolios.
- Dig — dig is a social listening platform using AI to analyze social video. Track brand mentions and sentiment analysis with our real-time media monitoring tool.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Avishai Abrahami is our Co-Founder, has served as our Chief Executive Officer since September 2010 and was our Co-Chief Executive Officer and a director since October 2006. From 2004 to 2006, Avishai was the Vice President of Strategic Alliances at Arel Communications & Software Ltd., a private Israeli company specializing in communicationtechnology. In 1998 he co-founded Sphera Corporation, a private company which develops software for managing data centers, and he served as its Chief Technology Officer from 1998 until 2000 and its Vice President of Product Marketing from 2000 until 2003. In 1993, he co-founded AIT Ltd., a private Israeli software company, and served as its Chief Technology Officer until the company's sale in 1997. Avishai served in the Israeli Defense Forces' elite computer intelligence unit from 1990 until 1992.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Italy
Investor stats
- Total investments: 19
- Round size: Seed $250k–$8M; Pre-Seed $1.2M–$7M; Series A $13M–$35M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Willow — The AI basecamp for the enterprise.Willow (formerly Webrix) connects any AI agent (Claude, ChatGPT, Cursor) to your internal systems with the visibility security needs and the enablement teams want. SSO, RBAC, audit trail, and runtime guards, built in.You'll find: - Technical deep dives on MCP, agents, and AI governance - Enterprise AIadoption playbooks (not hype) - Real implementation walkthroughs from production deployments - Conversations with CISOs, platform leaders, and AI adoption ownersBuilt for: CISOs, VPs of Engineering, platform leads, and CTOs rolling out AI at scale.
- Marquee — Marquee AI is a Sports tech company that develops advanced AI platforms to analyze recruitment, scouting and performance of the player.
- CustoMED — CustoMed transforms surgical planning and execution. It does this by converting medical imaging into 3D visualizations, planning procedures, and producing customized 3D-printed surgical solutions at scale in a matter of minutes, all while streamlining the process and providing surgical excellence.
Andrej Steinberg
Show more...Investment focus
- Industry: Health Care, Medical, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Germany, Israel
Investor stats
- Total investments: 9
- Round size: Seed $3.4M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Avallon Labs — Avallon Labs automates insurance claims operations with AI agents that handle calls and data entry to streamline adjuster workflows.
- Membrane — Membrane is AI for product integrations. Describe what you need, watch integrations build, test and maintain themselves.We exist to let any product connect to any other reliably, safely, and at scale, by turning intent & customer needs into integrations with AI.Our platform offers the state-of-the-art solution in the AI Age for productintegrations:Membrane Agent builds integrations for one or multiple apps at once, choosing correct API calls, field mappings, and data structuresMembrane Engine is the configurable infrastructure that you or any agent can play with. It contains actions, events/webhooks, flows, data collections, unified API models, field mappings, and schemas & more used to build and maintain integrations at scale.Membrane Packages - integration code that is purpose built for your use case, that you can deploy in your IDE.Membrane is used by 100+ B2B SaaS companies like Constant Contact, PandaDoc, Dialpad, Storyblok & many others as their preferred integration partner
- Lindus — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Ron Zuckerman is based out of Berlin, Berlin, and is the Advisory Council of Börse Stuttgart group. Ron previously worked at Attunity as a Board Member.
Show more...Investment focus
- Industry: Internet, Video, Apps
- Stage:Series A, Seed
- Geography: Israel, United States, China
Investor stats
- Total investments: 18
- Round size: Seed $500k–$8M; Series A $1M–$8M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Craft.io — Plan & manage your products with craft.io. A comprehensive, streamlined, intuitive product management platform built for product managers.
- MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
- Safeguard Applied Innovation — Safeguard Applied Innovation provides a mobile performance management platform for construction enterprises. It designs its solution to enable decision-making for successful project planning and execution, delivering effective control regardless of project complexity or national regulations.
Avi Kornreich is a former CEO of Agentek.
Show more...Investment focus
- Industry: Medical, Hospital, Health Care
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
Dr. Cabilly is a highly regarded scientist, an investor and an experienced Board Member of several companies. He is currently a Board Member of Medasense Biometrics Ltd. He previously worked for several companies including as the Co-Founder and a Chief Scientist of Ethrog Biotechnology which was sold to Invitrogen. Dr. Cabilly graduated fromthe Hebrew University (Ph.D., Immunology), and was a Post-Doctoral fellow at the City of Hope Research Institute heading a joint City of Hope/Genentech project where he developed a new technology for recombinant antibody production. This invention was patented in world patents “The old Cabilly” and “The New Cabilly patent”. Today there are already 20 drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series B, Series C
- Geography: Israel, United States
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Treato — Treato automatically collects the massive amount of patient-written health experiences from blogs and forums and, with advanced Natural Language Processing (NLP), extracts relevant information, connects the dots and creates the big picture of what people say about their medications and conditions.Treato's big data analytics are availablein a consumer site and as an in-depth service for pharmaceutical marketers.Treato's Consumer site (
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Medical Device Angel investor funding in Israel at a glance
Stats across 54 deals from 53 investors.
Access all 53 angel investors in Israel Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Angel Investors in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 53 angel investors investing in Israel Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!